Page 340 - Health Medical Pharma

Early-life alcohol intake may increase prostate cancer risk

Consuming at least seven drinks of alcohol per week in your adolescence may increase the risk of high grade prostate cancer later, a new study has found.

Organ transplantation from brain dead person in city again

In a span of six days, the city today witnessed another organ donation and transplantation from a 59-year-old brain dead person, a state health department official said. The donor, a resident of Chitpur area, was declared brain dead last evening and with the permission of the state Nodal office for organ transplantation, transplant specialists of the citys Apollo Gleneagles hospital retrieved one kidney and conducted the transplant in their facility in the wee hours. The recipient, who is a 58-year-old resident of the citys Tangra area, was suffering from chronic kidney disease and on the transplant list. The transplantation was successfully performed, a doctor said, adding that the operation was uneventful and the patient was under observation. Meanwhile, the liver and the second kidney of the donor were harvested by the government-run SSKM hospital doctors late last night at the private hospital. Both the organs were rushed to the SSKM hospital from the private ...

Warm room temperatures may help lower BP

Turning up the thermostat may help manage hypertension, according to a study that has found a link between indoor temperatures and blood pressure. Comparing blood pressure readings of people in their own homes with temperature readings, the researchers found that lower indoor temperatures were associated with higher blood pressure. "Our research has helped to explain the higher rates of hypertension, as well as potential increases in deaths from stroke and heart disease, in the winter months, suggesting indoor temperatures should be taken more seriously in diagnosis and treatment decisions, and in public health messages," said Stephen Jivraj, from University College London in the UK. "Among other diet and lifestyle changes people can make to reduce high blood pressure, our findings suggest that keeping homes a bit warmer could also be beneficial," said Jivraj. The researchers found that every one degree Celsius decrease in indoor temperature was associated with rises of 0.48 mmHg in ..

Dr Reddy's Labs gets EIR from USFDA for Srikakulam unit

Dr Reddy's Laboratories today said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Srikakulam facility in Andhra Pradesh. The Srikakulam unit manufactures active pharmaceutical ingredients (APIs). The EIR from the United States Food and Drug Administration (USFDA) indicates closure of the audit of the plant, Dr Reddy's Labs said in a BSE filing. In an earlier filing on June 2, 2018, the company had said that the audit of the Srikakulam plant (SEZ) by USFDA had been completed with no observations. Shares of Dr Reddy's Labs were trading at Rs 2,467.05 per scrip on BSE, up 2.26 per cent from the previous close.

Vaping, smoking together up heart attack risk by 5 times

Daily use of e-cigarettes combined with traditional smoking can lead to a five-fold increase in the odds of heart attack, according to study which also found that vaping alone doubles the risk. The study, published in the American Journal of Preventive Medicine, examined the relationship between e-cigarette use and heart attacks, and begins to fill the understanding of the effects of e-cigarettes on long-term health. "Most adults who use e-cigarettes continue to smoke cigarettes," said senior author Stanton Glantz, a professor at University of California - San Francisco in the US. "While people may think they are reducing their health risks, we found that the heart attack risk of e-cigarettes adds to the risk of smoking cigarettes," Glantz said. "Using both products at the same time is worse than using either one separately. Someone who continues to smoke daily while using e-cigarettes daily increases the odds of a heart attack by a factor of five," he said. The research found that ...

Apollo Hospitals Navi Mumbai launches Mazor Robotic Spine Surgery

Apollo Hospitals Navi Mumbai, one of the most advanced multi-specialty tertiary care hospitals in Maharashtra, launched Mazor Robotic Spine Surgery Systems for patients requiring spine surgery.Apollo Hospitals Navi Mumbai would be the first hospital in Western India to offer this advanced minimally invasive robotic system for the benefit of patients.The Robotic Spine Surgery Systems helps in increasing the accuracy of minimally invasive spine surgery through 3D mapping of the area to be operated. This enables surgeons to perform surgeries such as spinal fusion surgery, complex deformity and revision spine surgeries in conditions like degenerative disc diseases causing back pain, spinal stenosis, fractures, and tumours, it offers more precision as compared to traditional open surgery. The increased accuracy also helps in reducing the radiation exposure to patients. Additionally, there is less post-operative pain and quicker recovery.Dr. Ram Chaddha, Senior Consultant, Spine Surgeon, ...

Cadila Healthcare Ltd up for fifth session

The stock is quoting at Rs 394.8, up 1.9% on the day as on 12:44 IST on the NSE. Cadila Healthcare Ltd is down 20.14% in last one year as compared to a 17.47% spurt in NIFTY and a 13.61% spurt in the Nifty Pharma.

Lupin forays Brazil's dermatology market with launch of Fillerina and Recrexina

Valued at USD 28 billion, Brazil is the world's 6th largest pharmaceutical market, driven by growing public health expenditure and increasing household income. The dermatology segment in Brazil, worth USD 1.5 billion, and growing at 10% (CAGR) is one of the fastest growing segments in the country.

All you need to know about hepatitis

According to the World Health Organisation (WHO), hepatitis is one of the widely-recognised public health diseases in India, and liver diseases are the 10th most common cause of death in the country.

Sensex, Nifty retreat from record high

Key benchmark indices sink in negative zone in morning trade after an initial upmove pushed the Sensex and the Nifty to record highs. At 10:15 IST, the barometer index, the S&P BSE Sensex, was down 23.21 points or 0.06% at 38,262.54. The Nifty 50 index was down 14.60 points or 0.13% at 11,556.30. Pharma shares gained.

E-cigarette users at higher risk of heart attack

A new study has found that smoking an e-cigarette on a regular basis could double the risk of a heart attack.According to a new analysis of a survey of nearly 70,000 people, led by researchers at UC San Francisco, the dual use of e-cigarettes and conventional cigarettes appears to be more dangerous than using either product alone.The study also found that the risks compound, so that daily use of both e-cigarettes and conventional cigarettes raises the heart attack risk five-fold in comparison to the people who don't use either product.Senior author Stanton Glantz said, "Most adults who use e-cigarettes continue to smoke cigarettes. While people may think they are reducing their health risks, we found that the heart attack risk of e-cigarettes adds to the risk of smoking cigarettes."However, the researchers also reported some good news if smokers quit. "The risk of heart attack starts to drop immediately after you stop smoking. Our results suggest the same is true when they stop using .

Lupin gains after tentative USFDA approval for generic Nudovra tablets

Lupin rose 2.38% to Rs 910.40 at 9:49 IST on BSE after the company said it received US drug regulator's tentative approval for generic Nudovra tablets.

Maternal depression may affect child's immune and psychological health

Turns out, depression in mothers may have long-term effects on their children's stress and physical well-being.In a new study, researchers followed 125 children from birth to 10 years. At 10 years, mother's and children's cortisol (CT) and secretory immunoglobulin (s-IgA)--markers of stress and the immune system--were measured, mother-child interaction was observed, mothers and children underwent psychiatric diagnoses, and children's externalizing and internalizing symptoms were reported.Depressed mothers had higher CT and s-IgA levels and displayed more negative parenting, characterised by negative effect, intrusion, and criticism. Children of depressed mothers tended to exhibit certain psychiatric disorders, having higher s-IgA levels, and displayed greater social withdrawal.Senior author Dr. Ruth Feldman said, "Following mothers and children across the first decade of life, we found that exposure to maternal depression impairs the functioning of the child's immune system and stress

Market nudges higher in early trade

Domestic stocks edged higher in early trade. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 63.34 points or 0.17% at 38,349.09. The Nifty 50 index was up 19.05 points or 0.16% at 11,589.95.

Market may open on a firm note

Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could gain 33 points at the opening bell.

Lupin in focus after USFDA approval for generic

Lupin announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) to market a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Natazia tablets. Lupin's Nudovra (Estradiol Valerate tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest tablets, 2 mg/2 mg and 2 mg/3 mg) tablets is the generic versional Bayer HealthCare Pharmaceuticals Inc.'s Natazia tablets. It is an estrogen/progestin combined oral contraceptive (COC), indicated for use by women to prevent pregnancy. Nudovra (Estradiol Valerate tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest tablets, 2 mg/2 mg and 2 mg/3 mg) tablets had annual sales of approximately $31.40 million in the US (IQVIA MAT June 2018). The announcement was made on Wednesday, 22 August 2018.

Sleep medication: Use and abuse

Insomnia or sleep disturbance is the most common of all sleep disorders. Insomnia is the difficulty in falling asleep or staying asleep, even when a person can sleep in.According to a report by the National Institutes of Health, it is estimated that around 30 per cent of the total general population complains about sleep disruption and over 10 per cent have been associated with symptoms of daytime functional impairment consistently, with the diagnosis of insomnia.Treatment of insomnia depends on the severity of symptoms and underlying cause. Sleep medications are not the first line of treatment, and various other methods such as behavioural therapy or sleep hygiene must be tried first. Sleeping pills have a potential to make a person dependent on it when he/she takes those pills for a prolonged period.Dr Mohammed Shakeel of Fortis Hospital, Kalyan, said the risks and benefits of various prescriptions for sleeping pills can differ.Side effects of taking sleeping pills- Depending on the

Here's how indoor temperature affects blood pressure

According to a recent study, one can manage hypertension by turning up the thermostat.Comparing blood pressure readings of people in their own homes with temperature readings, the researchers at University College London found that lower indoor temperatures were linked to higher blood pressure."Our research has helped to explain the higher rates of hypertension, as well as potential increases in deaths from stroke and heart disease, in the winter months, suggesting indoor temperatures should be taken more seriously in diagnosis and treatment decisions, and in public health messages," said senior author Dr Stephen Jivraj."Among other diet and lifestyle changes people can make to reduce high blood pressure, our findings suggest that keeping homes a bit warmer could also be beneficial," he added.The researchers found that every one degree Celsius decrease in indoor temperature was associated with a rise of 0.48 mmHg in systolic blood pressure and 0.45 mmHg in diastolic blood ...

Breastfeeding mothers have lower risk of stroke: Study

Mothers, take note. Breastfeeding may reduce the risk for stroke in post-menopausal women, a new study has found.

Strides gets US regulatory nod for 2 generic drugs

The US Food and Drug Administration (FDA) has approved the application of pharma major Strides' arm to market two generic drugs for therapy in North America, said the company on Wednesday.